Abstract:To the editor, We read the recent study by Moore et al.[1] reporting that compromised hepatic fatty acid oxidation (FAO) and mitochondrial turnover are closely related to NAFLD severity in obese patients. The article greatly increases our understanding of the role of mitochondria in the pathogenesis of NAFLD, but we still had some concerns about the results that require attention. First, mitochondrial homeostasis, a prerequisite for mitochondrial functions, is majorly orchestrated by mitochondrial biogenesis and mitophagy. The perturbation between mitochondrial biogenesis and mitophagy causes the dysfunction of the mitochondria pool, which results in less ATP production and more reactive oxygen species (ROS) generation.[2] Hepatic mitochondrial biogenesis, mitophagy, and dynamics of patients with B‐NASH and D‐NASH were impaired in the current study, which further contribute to round, swollen, hypodense mitochondria with loss of cristae. The declined ATP production and accumulated ROS generation are a sure result. However, the protein content of hepatic OXPHOS complexes did not differ across groups. At the same time, the whole‐liver antioxidant defense system markers of protein content are not declined. Altogether, it is hard to explain that the mitochondrial ATP and ROS generation were significantly changed. It is well known that mitochondrial superoxide generated from the electron leak from Complexes I and III of electron transport chain during ATP production, and dysfunctional complex I and III trigger more superoxide generation.[3] We think that it is necessary to provide evidence of complex I and III activity not only for the ROS accumulation but also for the less energetic metabolism. Second, peroxisome proliferator‐activated receptor‐gamma coactivator (PGC‐1α), a co‐activator of peroxisome proliferator‐activated receptor gamma (PPARγ), is considered the master transcriptional regulator of mitochondrial biogenesis, but it is not enough to indicate the mitochondrial biogenesis by itself. PGC‐1a interacts with different transcription factors participating in multiple cellular activities including mitochondrial biogenesis, adaptive thermogenesis, angiogenesis, regulation of tricarboxylic acid cycle, gluconeogenesis, FAO, and oxidative phosphorylation.[4] Therefore, the dramatic reduction of mitochondrial biogenesis needs more evidence to confirm. Mitochondrial transcription factor A and mitochondrial DNA copy represent the direct mitochondrial biogenesis and need to be further determined. It should be noticed that deficient mitophagy might lead to damaged mitochondria accumulation, contributing to mDNA copy increase. Finally, mitophagy, a specific autophagic elimination of mitochondria, shares the most of molecular mechanic machinery with autophagy; thus, the interpretation of mitophagy needs more careful review. However, the study only detected the protein content of BCL2/adenovirus E1B19 kDa‐interacting protein 3 (BINP3), Phosphatase and tensin homolog (PTEN)‐induced kinase 1 (PINK1), and Parkinson's disease protein (PARKIN) of hepatic mitochondria. In actuality, the accumulated P62 and LC3 on mitochondria are more important to mitophagic flux.[5] We recommend that the authors further detect the P62 and LC3 of hepatic mitochondria. Another question to be answered is why a low level of ethanol is a mitochondrial biogenesis activator. In conclusion, we agree with the investigators’ conclusion that compromised hepatic FAO and dysfunctional mitochondria are closely related to NAFLD severity in obese patients. However, further studies are required to determine the mitochondrial biogenesis, the mitophagy, and the Complexes’ activity alteration in obese patients with NAFLD. CONFLICT OF INTEREST Nothing to report.

Ataxia Telangiestasia Mutated (ATM) Inhibition Disrupts Nuclear And Mitochondrial Homeostasis In Pediatric Nonalcoholic Fatty Liver Disease (PNAFLD)

Sa1668 Proteomic Analysis of Nonalcoholic Fatty Liver Disease: Attenuation of Coactosin-like Protein-1 Protects Liver from Steatosis and Injury

Sa1667 Hepatic-Specific Activation of Peroxisome Proliferator-Activated Receptor Y Coactivator-1α Protected Against Steatohepatitis

Sa1666 IGFBP1 Decreases Free Fatty Acid-Induced Hepatocyte Steatosis through Phosphorylation of FAK

Betaine Alleviates Nonalcoholic Fatty Liver Disease (NAFLD) Via a Manner Involving BHMT/FTO/m6A/ PGC1α Signaling.

Ataxia-Telangiectasia Mutated (ATM) loss of function displays variant and tissue-specific differences across tumor types

Impaired arterial dilation and increased NOX2 generated oxidative stress in subjects with ataxia-telangiectasia mutated (ATM) kinase

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Modulation of proteostasis counteracts oxidative stress and affects DNA base excision repair capacity in ATM-deficient cells

Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children

ATM phosphorylation of CD98HC increases antiporter membrane localization and prevents chronic toxic glutamate accumulation in Ataxia telangiectasia

Loss of mitochondrial ATPase ATAD3A contributes to nonalcoholic fatty liver disease through accumulation of lipids and damaged mitochondria

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

ATGL-mediated lipolysis is essential for myocellular mitochondrial function and augments PPARδ-induced improvements in mitochondrial respiration

Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia

ATM modulates nuclear mechanics by regulating lamin A levels

Letter to the Editor: Compromised Hepatic Mitochondrial Fatty Acid Oxidation and Reduced Markers of Mitochondrial Turnover in Human NAFLD

Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis

ATAXIA TELANGIECTASIA MUTATED PROTECTS AGAINST LIPOPOLYSACCARIDE-INDUCED BLOOD-BRAIN BARRIER DISRUPTION BY REGULATING ATK/DRP1-MEDIATED MITOCHONDRIAL HOMEOSTASIS.

ALCAT1 Controls Mitochondrial Etiology of Fatty Liver Diseases, Linking Defective Mitophagy to Steatosis.

ATM deficiency differentially affects expression of proteins related to fatty acid oxidation and oxidative stress in a sex-specific manner in response to Western-type diet prior to and following myocardial infarction